Key Takeaways Novo Nordisk shares gained Monday as the company said it would present new data on the ability of semaglutide, ...

Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

Pharmaceutical company Morepen Laboratories Ltd on Monday (March 17) said it has launched a new treatment for Type 2 diabetes ...

A new study from the University of Bologna has raised concerns about a common blood pressure medication called beta-blockers.

Valentine’s Day has come and gone, but it’s never too late to focus on your heart health. A groundbreaking new study suggests that sotagliflozin, a drug recently approved to treat type 2 ...

MedStar Health's Dr. Brian Case joined Fox 5 during Heart Health Month to talk new heart medications.

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

An Australian man lived for 100 days with an artificial titanium heart while he awaited a donor transplant, the longest ...

And new drugs to treat the other form of heart failure could also change the trajectory for patients with the disease. There are two main kinds. The first type is the one Ms. Ramirez experienced ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.